Portside Wealth Group, LLC Vertex Pharmaceuticals Inc Transaction History
Portside Wealth Group, LLC
- $613 Billion
- Q1 2025
A detailed history of Portside Wealth Group, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Portside Wealth Group, LLC holds 2,945 shares of VRTX stock, worth $1.5 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
2,945
Previous 2,266
29.96%
Holding current value
$1.5 Million
Previous $913 Million
56.47%
% of portfolio
0.23%
Previous 0.15%
Shares
10 transactions
Others Institutions Holding VRTX
# of Institutions
1,804Shares Held
223MCall Options Held
1.63MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$14.4 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$11.9 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.9 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$6.1 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$5.31 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $131B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...